The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor α-mediated apoptosis by activation of phosphoinositol 3-kinase and β-catenin
Authors:
- 1 December 2007
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 88 (12) , 3275-3285
Abstract
Hepatitis B x antigen (HBxAg) contributes significantly to the pathogenesis of chronic infection and development of hepatocellular carcinoma. To discern some of its operative pathways, HepG2 cells were stably transduced with HBx or the bacterial chloramphenicol acetyltransferase (CAT) gene. Differential gene expression has previously revealed an upregulated gene, clone 7 (URG7), that conferred resistance to anti-Fas killing on HepG2X cells. Given that tumour necrosis factor alpha (TNFα) is also an important mediator of chronic hepatitis, and partially shares signalling with Fas, experiments were designed to test whether URG7 blocks TNFα killing of HepG2X cells. HepG2X cells expressing URG7 and HepG2 cells overexpressing URG7 in the absence of HBxAg were resistant to TNFα killing compared with HepG2CAT cells. URG7 small interfering RNA restored the sensitivity of HepG2X cells to TNFα killing. Killing was associated with the activation of caspases 3 and 8, suggesting that URG7 blocked these caspases. This resistance was also associated with activation of phosphoinositol 3-kinase/Akt. Given that Akt and HBxAg also activate β-catenin, experiments were designed to determine whether URG7 blocked apoptosis via activation of β-catenin. Both HBxAg and URG7 activated fragments of the β-catenin promoter, and also promoted expression of β-catenin target genes. Hence, URG7 inhibits TNFα-mediated killing by blocking one or more caspases in the apoptotic pathway and by activating phosphoinositol 3-kinase and β-catenin, thereby overriding the apoptotic signalling of TNFα. This suggests that URG7 helps to protect virus-infected hepatocytes during chronic hepatitis B virus infection.Keywords
This publication has 46 references indexed in Scilit:
- Role of nuclear factor-κ B in melanomaCancer and Metastasis Reviews, 2005
- BCL-2 in prostate cancer: A minireviewApoptosis, 2003
- Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastasesCancer Letters, 2001
- Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X proteinEuropean Journal of Cancer, 2001
- X Protein of Hepatitis B Virus Inhibits Fas-mediated Apoptosis and Is Associated with Up-regulation of the SAPK/JNK PathwayJournal of Biological Chemistry, 2001
- Truncated Form of β‐Catenin and Reduced Expression of Wild‐Type Catenins Feature HepG2 Human Liver Cancer CellsAnnals of the New York Academy of Sciences, 1999
- Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathwayOncogene, 1998
- The Activation of p38 and Apoptosis by the Inhibition of Erk Is Antagonized by the Phosphoinositide 3-Kinase/Akt PathwayJournal of Biological Chemistry, 1998
- Hepatitis B virus immunopathologySpringer Seminars in Immunopathology, 1995
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979